Spearheading a Novel Compound Targeting the IL-4Ra Cytokine Receptor in Atopic Dermatitis

Time: 12:00 pm
day: Day 1 AM - Track A

Details:

  • Describing the target binding and Th2 cell modulation
  • Clinical responses from a phase 2b clinical trial in atopic dermatitis
  • Future clinical development

Speakers: